Morph

by BeauBrain Healthcare — Predict and Prevent Alzheimer's Disease
Geriatrics Neurology Radiology

Regulatory Status Disclosed

Overview

BeauBrain Healthcare envisions a world free from the fear of dementia. The company is developing an artificial intelligence (AI) program to predict ATN biomarkers for early diagnosis of dementia, as well as digital therapeutics (DTx) for preventing and treating the disease. Their ultimate goal is to become a leader in precision medicine for dementia by creating a platform for brain health management. BeauBrain Healthcare offers integrated solutions encompassing digital cognitive assessments, AI-powered brain imaging analysis, cognitive training, and blood biomarker algorithms. The company’s platform utilizes a suite of cognitive tests and brain imaging scans to predict the risk of developing Alzheimer’s and other forms of dementia by analyzing brain activity and structure, identifying subtle changes before symptoms appear. This enables healthcare professionals to take proactive steps to delay or prevent the onset of cognitive decline, such as personalized cognitive training programs and lifestyle modifications.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered brain MRI analysis
  • Automatic labeling, visualization, and volumetric quantification of brain structures
  • Quantitative assessments of brain structure volumes
  • Comparison to reference percentile data
  • Supports clinical decision-making for neurodegeneration
  • Utilizes deep learning algorithms
  • Cloud-based deployment option
  • Predicts ATN biomarkers for early dementia diagnosis
  • Offers personalized cognitive training programs
  • Processes 2D MRI scans

Use Cases

  • Early diagnosis of Alzheimer's disease and other dementias
  • Prediction of ATN biomarkers
  • Monitoring of neurodegeneration through brain volume changes
  • Supporting clinical decisions in radiology and neurology settings
  • Personalized cognitive training for prevention and treatment
  • Analyzing brain activity and structure to identify early changes

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentCloud-based (SaaS) or on-premise
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Geriatrics, Neurology, Radiology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2026-05-13K260032 510(k)Morph

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Morph

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Morph.

Loading videos...

View all on YouTube

No FAQs available yet for this tool.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-19 | First Added: 2026-11-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.